(Q84628841)
Statements
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma (English)
P A Thompson
H M Prince
J F Seymour
D Ritchie
K Stokes
K Burbury
M Wolf
S Peinert